Zepteon, Inc. is a privately held corporation founded in 2012 that has developed first in class chromatography resins capable of separating antibodies with specific sugar structures (nonfucosylated) that are more potent against diseases like cancer. This technology enables more effective therapeutics and can reduce cost and dosing requirements.
Company Details
- Employees
- 4
- Founded
- 2012
- Address
- Boston, Massachusetts 02111, Us
- Phone
- (617) 216-6144
- in****@****eon.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.zepteon.com/
- Keywords
- antibody purification, afucosylated antibodies, nonfucosylated antibodies, antibody glycoform purification, Fc receptors, effector function, hyperimmune IgG, IVIG, autoimmunity therapies, anti-viral therapies, inflammation therapies, cancer therapies, immunotherapies.
- HQ
- Boston, Massachusetts
Zepteon, Inc. Questions
Zepteon, Inc.'s helpline number is (617) 216-6144
Zepteon, Inc.'s website is https://www.zepteon.com/
Zepteon, Inc.'s LinkedIn profile is https://www.linkedin.com/company/zepteon-inc-
Zepteon, Inc. has
4 employees.
View email and phone details for 4
employees at Zepteon, Inc..
Zepteon, Inc.'s industry is
Biotechnology Research
Zepteon, Inc.'s top competitors are
Virion Therapeutics, Llc,
Avobis Bio,
Pmconsultinggroup Gmbh,
Jibe Therapeutics,
Acousticabio,
Speratum Biopharma, Inc.,
Rockids Company,
Nrx Pharmaceuticals, Inc.,
Lumigenics Llc,
Dharma Bioscience.
Zepteon, Inc.'s support email address is info@zepteon.com
Zepteon, Inc.'s categories are Biotechnology Research
Zepteon, Inc.'s founding year is 2012
